XML 60 R47.htm IDEA: XBRL DOCUMENT

Supplemental Data (Tables)

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Statements of Operations



For the three months ended June 30, 2019	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Patient services revenues	$	—		$	1,781,066		$	1,014,869		$	(61,870	)	$	2,734,065
Provision for uncollectible accounts	—			(7,246		)	(3,003		)	—			(10,249		)
Net patient service revenues	—			1,773,820			1,011,866			(61,870		)	2,723,816
Other revenues	207,299			115,226			37,035			(240,671		)	118,889
Total net revenues	207,299			1,889,046			1,048,901			(302,541		)	2,842,705
Operating expenses	160,464			1,673,331			849,565			(302,541		)	2,380,819
Operating income	46,835			215,715			199,336			—			461,886
Debt expense	(144,896		)	(52,762		)	(11,217		)	65,049			(143,826		)
Other income, net	102,059			2,716			8,958			(108,090		)	5,643
Income tax expense	627			63,930			11,381			—			75,938
Equity earnings in subsidiaries	270,180			168,441			—			(438,621		)	—
Net income from continuing operations	273,551			270,180			185,696			(481,662		)	247,765
Net income from discontinued operations, net of tax	—			—			36,351			43,041			79,392
Net income	273,551			270,180			222,047			(438,621		)	327,157
Less: Net income attributable to noncontrolling interests	—			—			—			(53,606		)	(53,606		)
Net income attributable to DaVita Inc.	$	273,551		$	270,180		$	222,047		$	(492,227	)	$	273,551



For the three months ended June 30, 2018	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Patient service revenues	$	—		$	1,831,545		$	936,646		$	(49,788	)	$	2,718,403
Provision for uncollectible accounts	—			(27,159		)	(22,247		)	—			(49,406		)
Net patient service revenues	—			1,804,386			914,399			(49,788		)	2,668,997
Other revenues	205,317			214,266			43,137			(244,764		)	217,956
Total net revenues	205,317			2,018,652			957,536			(294,552		)	2,886,953
Operating expenses and charges	145,649			1,850,377			747,287			(294,552		)	2,448,761
Operating income	59,668			168,275			210,249			—			438,192
Debt expense	(120,814		)	(52,363		)	(9,274		)	62,759			(119,692		)
Other income, net	105,344			2,856			4,440			(110,646		)	1,994
Income tax expense	13,257			40,019			30,592			—			83,868
Equity earnings in subsidiaries	236,335			157,586			—			(393,921		)	—
Net income from continuing operations	267,276			236,335			174,823			(441,808		)	236,626
Net income from discontinued operations, net of tax	—			—			21,809			47,887			69,696
Net income	267,276			236,335			196,632			(393,921		)	306,322
Less: Net income attributable to noncontrolling interests	—			—			—			(39,046		)	(39,046		)
Net income attributable to DaVita Inc.	$	267,276		$	236,335		$	196,632		$	(432,967	)	$	267,276



For the six months ended June 30, 2019	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Patient services revenues	$	—		$	3,558,312		$	1,933,473		$	(122,568	)	$	5,369,217
Provision for uncollectible accounts	—			(11,216		)	(4,496		)	—			(15,712		)
Net patient service revenues	—			3,547,096			1,928,977			(122,568		)	5,353,505
Other revenues	396,135			226,367			72,654			(462,844		)	232,312
Total net revenues	396,135			3,773,463			2,001,631			(585,412		)	5,585,817
Operating expenses and charges	304,123			3,333,784			1,730,929			(585,412		)	4,783,424
Operating income	92,012			439,679			270,702			—			802,393
Debt expense	(278,491		)	(105,241		)	(21,936		)	130,323			(275,345		)
Other income, net	212,257			5,312			18,069			(223,055		)	12,583
Income tax expense	7,653			110,474			14,557			—			132,684
Equity earnings in subsidiaries	404,715			175,439			—			(580,154		)	—
Net income from continuing operations	422,840			404,715			252,278			(672,886		)	406,947
Net income from discontinued operations, net of tax	—			—			16,965			92,732			109,697
Net income	422,840			404,715			269,243			(580,154		)	516,644
Less: Net income attributable to noncontrolling interests	—			—			—			(93,804		)	(93,804		)
Net income attributable to DaVita Inc.	$	422,840		$	404,715		$	269,243		$	(673,958	)	$	422,840



For the six months ended June 30, 2018	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Patient services revenues	$	—		$	3,621,733		$	1,785,047		$	(97,303	)	$	5,309,477
Provision for uncollectible accounts	—			(17,531		)	(6,330		)	—			(23,861		)
Net patient service revenues	—			3,604,202			1,778,717			(97,303		)	5,285,616
Other revenues	400,882			419,226			114,070			(483,397		)	450,781
Total net revenues	400,882			4,023,428			1,892,787			(580,700		)	5,736,397
Operating expenses and charges	279,005			3,641,471			1,547,743			(580,700		)	4,887,519
Operating income	121,877			381,957			345,044			—			848,878
Debt expense	(235,148		)	(104,560		)	(16,649		)	123,149			(233,208		)
Other income, net	209,425			5,379			10,144			(218,372		)	6,576
Income tax expense	27,644			88,962			37,999			—			154,605
Equity earnings in subsidiaries	377,452			183,638			—			(561,090		)	—
Net income from continuing operations	445,962			377,452			300,540			(656,313		)	467,641
Net (loss) income from discontinued operations, net of tax	—			—			(31,313		)	95,223			63,910
Net income	445,962			377,452			269,227			(561,090		)	531,551
Less: Net income attributable to noncontrolling interests	—			—			—			(85,589		)	(85,589		)
Net income attributable to DaVita Inc.	$	445,962		$	377,452		$	269,227		$	(646,679	)	$	445,962

Condensed Consolidating Statements of Income



For the six months ended June 30, 2019	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	5,369,217		$	—		$	—	$	5,369,217
Provision for uncollectible accounts	(15,712		)	—			—		(15,712		)
Net patient service operating revenues	5,353,505			—			—		5,353,505
Other revenues	232,312			—			—		232,312
Total net operating revenues	5,585,817			—			—		5,585,817
Operating expenses	4,783,424			—			—		4,783,424
Operating income	802,393			—			—		802,393
Debt expense	(275,345		)	—			—		(275,345		)
Other income	12,583			—			—		12,583
Income tax expense	132,684			—			—		132,684
Net income from continuing operations	406,947			—			—		406,947
Net income from discontinued operations, net of tax	109,697			12,706			249		96,742
Net income	516,644			12,706			249		503,689
Less: Net income attributable to noncontrolling interests	(93,804		)	(1,255		)	—		(92,549		)
Net income attributable to DaVita Inc.	$	422,840		$	11,451		$	249	$	411,140

(1)

After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



For the three months ended June 30, 2019	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Net income	$	273,551	$	270,180	$	222,047	$	(438,621	)	$	327,157
Other comprehensive income	1,575		—		12,365		—			13,940
Total comprehensive income	275,126		270,180		234,412		(438,621		)	341,097
Less: Comprehensive income attributable to noncontrolling interest	—		—		—		(53,606		)	(53,606		)
Comprehensive income attributable to DaVita Inc.	$	275,126	$	270,180	$	234,412	$	(492,227	)	$	287,491



For the three months ended June 30, 2018	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Net income	$	267,276	$	236,335	$	196,632		$	(393,921	)	$	306,322
Other comprehensive income (loss)	1,269		—		(50,529		)	—			(49,260		)
Total comprehensive income	268,545		236,335		146,103			(393,921		)	257,062
Less: Comprehensive income attributable to noncontrolling interest	—		—		—			(39,046		)	(39,046		)
Comprehensive income attributable to DaVita Inc.	$	268,545	$	236,335	$	146,103		$	(432,967	)	$	218,016



For the six months ended June 30, 2019	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Net income	$	422,840	$	404,715	$	269,243		$	(580,154	)	$	516,644
Other comprehensive income (loss)	2,601		—		(1,288		)	—			1,313
Total comprehensive income	425,441		404,715		267,955			(580,154		)	517,957
Less: Comprehensive income attributable to noncontrolling interest	—		—		—			(93,804		)	(93,804		)
Comprehensive income attributable to DaVita Inc.	$	425,441	$	404,715	$	267,955		$	(673,958	)	$	424,153



For the six months ended June 30, 2018	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Net income	$	445,962	$	377,452	$	269,227		$	(561,090	)	$	531,551
Other comprehensive income (loss)	3,856		—		(30,648		)	—			(26,792		)
Total comprehensive income	449,818		377,452		238,579			(561,090		)	504,759
Less: Comprehensive income attributable to noncontrolling interest	—		—		—			(85,589		)	(85,589		)
Comprehensive income attributable to DaVita Inc.	$	449,818	$	377,452	$	238,579		$	(646,679	)	$	419,170

Condensed Consolidating Statements of Comprehensive Income



For the six months ended June 30, 2019	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	516,644		$	12,706		$	249	$	503,689
Other comprehensive income	1,313			—			—		1,313
Total comprehensive income	517,957			12,706			249		505,002
Less: Comprehensive income attributable to the noncontrolling interests	(93,804		)	(1,255		)	—		(92,549		)
Comprehensive income attributable to DaVita Inc.	$	424,153		$	11,451		$	249	$	412,453

(1)

After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



As of June 30, 2019	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Cash and cash equivalents	$	3,374,887	$	—	$	200,751	$	—		$	3,575,638
Restricted cash and equivalents	1,007		12,181		93,584		—			106,772
Accounts receivable, net	—		1,352,844		657,957		—			2,010,801
Other current assets	37,185		545,881		114,352		—			697,418
Total current assets	3,413,079		1,910,906		1,066,644		—			6,390,629
Property and equipment, net	501,219		1,613,193		1,290,903		—			3,405,315
Operating lease right-of-use assets	105,137		1,636,360		1,049,388		—			2,790,885
Intangible assets, net	107		37,272		83,195		—			120,574
Investments in subsidiaries	11,304,840		3,184,913		—		(14,489,753		)	—
Intercompany receivables	—		1,563,270		1,483,874		(3,047,144		)	—
Other long-term assets and investments	80,491		81,567		196,113		—			358,171
Goodwill	—		4,821,054		2,044,332		—			6,865,386
Total assets	$	15,404,873	$	14,848,535	$	7,214,449	$	(17,536,897	)	$	19,930,960
Current liabilities	$	3,767,482	$	1,348,798	$	590,664	$	—		$	5,706,944
Intercompany payables	1,710,121		—		1,337,023		(3,047,144		)	—
Long-term operating leases liabilities	133,349		1,550,461		1,005,439		—			2,689,249
Long-term debt and other long-term liabilities	5,103,876		644,436		357,653		—			6,105,965
Noncontrolling interests subject to put provisions	640,747		—		—		544,986			1,185,733
Total DaVita Inc. shareholders' equity	4,049,298		11,304,840		3,184,913		(14,489,753		)	4,049,298
Noncontrolling interests not subject to put provisions	—		—		738,757		(544,986		)	193,771
Total equity	4,049,298		11,304,840		3,923,670		(15,034,739		)	4,243,069
Total liabilities and equity	$	15,404,873	$	14,848,535	$	7,214,449	$	(17,536,897	)	$	19,930,960



As of December 31, 2018	DaVita Inc.		Guarantor subsidiaries		Non- Guarantor subsidiaries		Consolidating adjustments			Consolidated total
Cash and cash equivalents	$	60,653	$	—	$	262,385	$	—		$	323,038
Restricted cash and equivalents	1,005		12,048		79,329		—			92,382
Accounts receivable, net	—		1,264,290		594,318		—			1,858,608
Other current assets	37,185		601,318		122,063		—			760,566
Current assets held for sale	—		—		5,389,565		—			5,389,565
Total current assets	98,843		1,877,656		6,447,660		—			8,424,159
Property and equipment, net	491,462		1,624,835		1,277,372		—			3,393,669
Intangible assets, net	153		42,933		75,760		—			118,846
Investments in subsidiaries	10,102,750		3,371,450		—		(13,474,200		)	—
Intercompany receivables	3,419,448		259,573		1,788,043		(5,467,064		)	—
Other long-term assets and investments	53,385		80,537		197,696		—			331,618
Goodwill	—		4,812,365		2,029,595		—			6,841,960
Total assets	$	14,166,041	$	12,069,349	$	11,816,126	$	(18,941,264	)	$	19,110,252
Current liabilities	$	1,945,943	$	1,251,534	$	449,925	$	—		$	3,647,402
Current liabilities held for sale	—		—		1,243,759		—			1,243,759
Intercompany payables	—		—		5,467,064		(5,467,064		)	—
Long-term debt and other long-term liabilities	7,918,581		715,065		552,406		—			9,186,052
Noncontrolling interests subject to put provisions	598,075		—		—		526,566			1,124,641
Total DaVita Inc. shareholders' equity	3,703,442		10,102,750		3,371,450		(13,474,200		)	3,703,442
Noncontrolling interests not subject to put provisions	—		—		731,522		(526,566		)	204,956
Total equity	3,703,442		10,102,750		4,102,972		(14,000,766		)	3,908,398
Total liabilities and equity	$	14,166,041	$	12,069,349	$	11,816,126	$	(18,941,264	)	$	19,110,252

Condensed Consolidating Balance Sheets



As of June 30, 2019	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	3,575,638	$	—	$	—	$	3,575,638
Restricted cash and equivalents	106,772		—		—		106,772
Accounts receivable, net	2,010,801		—		—		2,010,801
Other current assets	697,418		—		—		697,418
Total current assets	6,390,629		—		—		6,390,629
Property and equipment, net	3,405,315		—		—		3,405,315
Operating lease right-of-use assets	2,790,885		—		—		2,790,885
Amortizable intangibles, net	120,574		—		—		120,574
Other long-term assets	358,171		—		—		358,171
Goodwill	6,865,386		—		—		6,865,386
Total assets	$	19,930,960	$	—	$	—	$	19,930,960
Current liabilities	$	5,706,944	$	—	$	—	$	5,706,944
Long-term operating leases liabilities	2,689,249		—		—		2,689,249
Long-term debt and other long-term liabilities	6,105,965		—		—		6,105,965
Noncontrolling interests subject to put provisions	1,185,733		—		—		1,185,733
Total DaVita Inc. shareholders’ equity	4,049,298		—		—		4,049,298
Noncontrolling interests not subject to put provisions	193,771		—		—		193,771
Shareholders’ equity	4,243,069		—		—		4,243,069
Total liabilities and shareholder’s equity	$	19,930,960	$	—	$	—	$	19,930,960

(1)

After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



For the six months ended June 30, 2019	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Cash flows from operating activities:
Net income	$	422,840		$	404,715		$	269,243		$	(580,154	)	$	516,644
Changes in operating assets and liabilities and non-cash items included in net income	(292,988		)	(210,545		)	157,850			580,154			234,471
Net cash provided by operating activities	129,852			194,170			427,093			—			751,115
Cash flows from investing activities:
Additions of property and equipment	(63,037		)	(174,483		)	(136,398		)	—			(373,918		)
Acquisitions	—			(8,975		)	(56,995		)	—			(65,970		)
Proceeds from asset and business sales	3,824,509			33			26,839			—			3,851,381
Proceeds (purchases) from investment sales and other items, net	729			(6,560		)	(2,970		)	—			(8,801		)
Net cash provided by (used in) investing activities	3,762,201			(189,985		)	(169,524		)	—			3,402,692
Cash flows from financing activities:
Long-term debt and related financing costs, net	(1,152,510		)	(5,270		)	(6,329		)	—			(1,164,109		)
Intercompany borrowing (payments)	656,704			1,218			(657,922		)	—			—
Other items	(82,011		)	—			(64,433		)	—			(146,444		)
Net cash used in financing activities	(577,817		)	(4,052		)	(728,684		)	—			(1,310,553		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—			—			(77		)	—			(77		)
Net increase (decrease) in cash, cash equivalents and restricted cash	3,314,236			133			(471,192		)	—			2,843,177
Less: Net decrease in cash, cash equivalents and restricted cash from discontinued operations	—			—			(423,813		)	—			(423,813		)
Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations	3,314,236			133			(47,379		)	—			3,266,990
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	61,658			12,048			341,714			—			415,420
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	3,375,894		$	12,181		$	294,335		$	—		$	3,682,410



For the six months ended June 30, 2018	DaVita Inc.			Guarantor subsidiaries			Non- Guarantor subsidiaries			Consolidating adjustments			Consolidated total
Cash flows from operating activities:
Net income	$	445,962		$	377,452		$	269,227		$	(561,090	)	$	531,551
Changes in operating assets and liabilities and non-cash items included in net income	(361,134		)	31,554			161,514			561,090			393,024
Net cash provided by operating activities	84,828			409,006			430,741			—			924,575
Cash flows from investing activities:
Additions of property and equipment	(77,169		)	(216,103		)	(180,705		)	—			(473,977		)
Acquisitions	—			(6,916		)	(82,549		)	—			(89,465		)
Proceeds from asset and business sales	—			28,546			87,695			—			116,241
Proceeds (purchases) from investment sales and other items, net	32,415			(7,232		)	(2,046		)	—			23,137
Net cash used in investing activities	(44,754		)	(201,705		)	(177,605		)	—			(424,064		)
Cash flows from financing activities:
Long-term debt and related financing costs, net	584,500			(4,398		)	(6,121		)	—			573,981
Intercompany borrowing (payments)	224,359			(187,712		)	(36,647		)	—			—
Other items	(804,245		)	(13,208		)	(62,437		)	—			(879,890		)
Net cash provided by (used in) financing activities	4,614			(205,318		)	(105,205		)	—			(305,909		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—			—			(3,473		)	—			(3,473		)
Net increase in cash, cash equivalents and restricted cash	44,688			1,983			144,458			—			191,129
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations	—			—			229,901			—			229,901
Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations	44,688			1,983			(85,443		)	—			(38,772		)
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	150,307			9,384			359,229			—			518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	194,995		$	11,367		$	273,786		$	—		$	480,148

Condensed Consolidating Statements of Cash Flows



For the six months ended June 30, 2019	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	516,644		$	12,706		$	249		$	503,689
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	234,471			(4,607		)	(249		)	239,327
Net cash provided by operating activities	751,115			8,099			—			743,016
Cash flows from investing activities:
Additions of property and equipment	(373,918		)	(846		)	—			(373,072		)
Acquisitions	(65,970		)	—			—			(65,970		)
Proceeds from asset and business sales	3,851,381			—			—			3,851,381
Investments and other items	(8,801		)	(1,882		)	—			(6,919		)
Net cash provided by (used in) investing activities	3,402,692			(2,728		)	—			3,405,420
Cash flows from financing activities:
Long-term debt	(1,164,109		)	—			—			(1,164,109		)
Intercompany	—			(247,175		)	—			247,175
Other items	(146,444		)	—			—			(146,444		)
Net cash used in financing activities	(1,310,553		)	(247,175		)	—			(1,063,378		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(77		)	—			—			(77		)
Net increase (decrease) in cash, cash equivalents and restricted cash	2,843,177			(241,804		)	—			3,084,981
Less: Net decrease in cash, cash equivalents and restricted cash from discontinued operations	(423,813		)	(241,804		)	—			(182,009		)
Net increase in cash, cash equivalents and restricted cash from continuing operations	3,266,990			—			—			3,266,990
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	415,420			—			—			415,420
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	3,682,410		$	—		$	—		$	3,682,410

(1)

After elimination of the unrestricted subsidiaries and the physician groups.